Glaukos Corporation (GKOS)

NYSE: GKOS · Real-Time Price · USD

94.64

+1.65 (1.77%)

Jun 9, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Glaucoma	324.19M	Log In	Log In	Log In	Log In	Upgrade
Glaucoma Growth	30.71%	Log In	Log In	Log In	Log In	Upgrade
Corneal Health	80.33M	Log In	Log In	Log In	Log In	Upgrade
Corneal Health Growth	2.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
United States	287.48M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	26.42%	Log In	Log In	Log In	Log In	Upgrade
International	117.05M	Log In	Log In	Log In	Log In	Upgrade
International Growth	18.19%	Log In	Log In	Log In	Log In	Upgrade

	
		OSZAR »